Raymond James Financial Lowers Intuitive Surgical (NASDAQ:ISRG) Price Target to $577.00

Intuitive Surgical (NASDAQ:ISRG) had its target price reduced by equities researchers at Raymond James Financial from $615.00 to $577.00 in a report released on Wednesday,MarketScreener reports. The firm presently has an “outperform” rating on the medical equipment provider’s stock. Raymond James Financial’s price objective would suggest a potential upside of 20.40% from the stock’s previous close.

A number of other analysts have also commented on ISRG. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Intuitive Surgical in a report on Monday, December 29th. Evercore lowered their target price on shares of Intuitive Surgical from $550.00 to $480.00 and set a “neutral” rating for the company in a report on Monday, April 6th. Mizuho set a $525.00 target price on shares of Intuitive Surgical and gave the stock a “neutral” rating in a report on Monday, April 13th. Wall Street Zen lowered shares of Intuitive Surgical from a “buy” rating to a “hold” rating in a report on Saturday, February 7th. Finally, Piper Sandler lowered their target price on shares of Intuitive Surgical from $620.00 to $580.00 and set an “overweight” rating for the company in a report on Wednesday. Eighteen investment analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $585.17.

Intuitive Surgical Price Performance

Shares of Intuitive Surgical stock opened at $479.25 on Wednesday. The firm has a market cap of $170.20 billion, a P/E ratio of 61.00, a P/E/G ratio of 3.64 and a beta of 1.68. The firm has a 50 day simple moving average of $477.79 and a 200 day simple moving average of $515.63. Intuitive Surgical has a fifty-two week low of $427.84 and a fifty-two week high of $603.88.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings results on Tuesday, April 21st. The medical equipment provider reported $2.50 earnings per share for the quarter, beating analysts’ consensus estimates of $2.08 by $0.42. Intuitive Surgical had a net margin of 28.38% and a return on equity of 15.06%. The business had revenue of $2.77 billion during the quarter, compared to analyst estimates of $2.62 billion. During the same quarter last year, the business posted $1.81 earnings per share. Intuitive Surgical’s revenue for the quarter was up 23.0% compared to the same quarter last year. On average, sell-side analysts expect that Intuitive Surgical will post 8.16 EPS for the current year.

Insider Activity at Intuitive Surgical

In other news, EVP Myriam Curet sold 421 shares of Intuitive Surgical stock in a transaction on Wednesday, February 11th. The shares were sold at an average price of $494.96, for a total transaction of $208,378.16. Following the transaction, the executive vice president directly owned 409 shares of the company’s stock, valued at $202,438.64. This trade represents a 50.72% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, VP Fredrik Widman sold 133 shares of Intuitive Surgical stock in a transaction on Wednesday, February 11th. The stock was sold at an average price of $494.96, for a total transaction of $65,829.68. Following the transaction, the vice president directly owned 660 shares in the company, valued at approximately $326,673.60. This represents a 16.77% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last quarter, insiders sold 32,943 shares of company stock valued at $17,279,568. 0.60% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On Intuitive Surgical

A number of hedge funds and other institutional investors have recently made changes to their positions in the company. Cambient Family Office LLC boosted its position in shares of Intuitive Surgical by 6.0% during the first quarter. Cambient Family Office LLC now owns 19,030 shares of the medical equipment provider’s stock worth $8,773,000 after purchasing an additional 1,083 shares in the last quarter. Ground Swell Capital LLC boosted its position in shares of Intuitive Surgical by 131.5% during the first quarter. Ground Swell Capital LLC now owns 1,588 shares of the medical equipment provider’s stock worth $732,000 after purchasing an additional 902 shares in the last quarter. Granite Islands Private Wealth LLC boosted its position in shares of Intuitive Surgical by 4.9% during the first quarter. Granite Islands Private Wealth LLC now owns 4,181 shares of the medical equipment provider’s stock worth $1,918,000 after purchasing an additional 196 shares in the last quarter. Riverstone Advisors LLC boosted its position in shares of Intuitive Surgical by 10.3% during the first quarter. Riverstone Advisors LLC now owns 881 shares of the medical equipment provider’s stock worth $406,000 after purchasing an additional 82 shares in the last quarter. Finally, Crown Wealth Group LLC boosted its position in shares of Intuitive Surgical by 9.6% during the first quarter. Crown Wealth Group LLC now owns 527 shares of the medical equipment provider’s stock worth $243,000 after purchasing an additional 46 shares in the last quarter. 83.64% of the stock is owned by institutional investors.

Intuitive Surgical News Roundup

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Q1 beat — ISRG reported $2.50 EPS vs. ~$2.08 expected and $2.77B in revenue (up ~23% year-over-year), driven by robust demand for its robotic systems. Intuitive Surgical beats quarterly expectations on surgical robot demand (Reuters)
• Positive Sentiment: Raised procedure outlook — Management increased its 2026 da Vinci procedure growth guidance to roughly 13.5%–15.5% and noted expanding Force Feedback availability, signaling continued market adoption. Intuitive forecasts 13.5%-15.5% 2026 da Vinci procedure growth (Seeking Alpha)
• Positive Sentiment: Procedure mix strength — Worldwide procedures (da Vinci +16%, Ion +39%) and placements contributed to broad-based growth across general surgery and oncology, supporting long-term revenue drivers. Intuitive Announces First Quarter Earnings (GlobeNewswire)
• Positive Sentiment: Analyst support — Several firms reaffirm Buy ratings (BTIG, Truist and others) following results, leaving upside potential tied to execution and procedure adoption. BTIG reaffirms buy; coverage notes (TickerReport/Benzinga)
• Neutral Sentiment: Product & innovation progress — Management highlighted digital initiatives and broader availability of features (e.g., Force Feedback); these are strategic positives but will affect revenue gradually. Q1 highlights and digital innovation (Yahoo Finance)
• Negative Sentiment: Price-target cuts and cautious notes — TD Cowen cut its PT to $585 (from $660) while others trimmed targets ahead/of the print, which caps near-term upside. TD Cowen lowers PT to $585 (TipRanks)
• Negative Sentiment: Market reaction & valuation concerns — Despite the beat and a modest guide lift, the stock sold off after hours as investors parsed conservative commentary, international headwinds and valuation (calls to “not overpay”). Why Intuitive dropped despite beat (Yahoo Finance)

Intuitive Surgical Company Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.